We are live on
!
Find out more
MC
Menta Capital Portfolio holdings
AUM
$236M
1-Year Est. Return
6.6%
This Fund
S&P 500
This Quarter
Est. Return
+4.44%
1 Year Est. Return
+6.6%
3 Year Est. Return
+61.19%
5 Year Est. Return
+82.86%
10 Year Est. Return
–
AUM
$727M
AUM Growth
-$3.86M
(-0.53%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
7.84%
Holding
1,084
New
199
Increased
334
Reduced
260
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DF
Dean Foods Company
DF
|
+$3.17M |
| 2 |
Omega Healthcare
OHI
|
+$2.8M |
| 3 |
Cencora
COR
|
+$2.53M |
| 4 |
Becton Dickinson
BDX
|
+$2.14M |
| 5 |
CYS
CYS Investments Inc.
CYS
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$7.51M |
| 2 |
TechnipFMC
FTI
|
+$3.35M |
| 3 |
Kimco Realty
KIM
|
+$3.18M |
| 4 |
F5
FFIV
|
+$3.08M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$3.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.02% |
| 2 | Technology | 15.9% |
| 3 | Real Estate | 15.68% |
| 4 | Industrials | 12.52% |
| 5 | Financials | 10.03% |
Similar funds
MM
HI
BLA
FAM
PSG
ACM
SC
MBT
Menta Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Menta Capital held 1,084 positions worth $727M, down 0.53% from $731M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Menta Capital's Q2 2016 filing shows 199 new, 334 increased, 260 reduced and 249 closed positions. Its largest new stake was Cencora: 31,500 shares worth $2.5M. The largest sale was Teva Pharmaceuticals, an estimated $7.51M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Technology and Real Estate.
- Menta Capital's largest Q2 2016 buy was Cencora: 31,500 shares worth $2.5M.
- Menta Capital added most to Dean Foods Company in Q2 2016, an estimated $3.17M increase.
- Menta Capital's biggest Q2 2016 reduction was Kimco Realty, cutting an estimated $3.18M.
- Menta Capital fully exited Teva Pharmaceuticals in Q2 2016, selling an estimated $7.51M.
- Menta Capital's ten largest holdings make up 7.8% of its $727M portfolio in Q2 2016.
- Menta Capital opened 199 new positions and closed 249 in Q2 2016.
- Menta Capital's portfolio value fell 0.53% quarter-over-quarter to $727M.
Based on Menta Capital's 13F filing for Q2 2016, filed 12 Aug 2016.